levels has also been associated with significant increases in the risk of stroke, 11 as well as outcomes in other disease states, including severe sepsis and septic shock. [12] [13] [14] [15] ADMA is metabolized by dimethylarginine dimethylaminohydrolase (DDAH) to dimethylamine and citrulline. 16 Two isoforms of DDAH exist which have differing distributions throughout the body.
16, 17 The first isoform DDAH1 is found in diffuse tissue sites and has been shown to play a major physiological role in both basal 10 and pathological states 18 via its actions in regulating NO production. Inhibiting the DDAH1 enzyme pharmacologically has been shown to improve mortality in animal models of severe sepsis 18, 19 because of attenuation of NO synthesis in the vasculature. It has been suggested that the second isoform (DDAH2) may have complementary and independent physiological roles. 20 Its temporal and spatial colocalization with DDAH1 in the vasculature suggests that it may be involved in regulating vascular tone. Furthermore, its genetic location in the major histocompatibility complex III region of chromosome 6 16 , the fact that it is the only isoform expressed in immune cells 17 together with preliminary data demonstrating an association between human DDAH2 promoter polymorphisms and outcome in sepsis 13, 14 has led to the suggestion that DDAH2 may play a role in regulating the immune response.
In this study, we characterize for the first time the physiological role of DDAH2 by demonstrating the impact of Ddah2 knockout in the mouse on ADMA homeostasis, NO production, and cardiovascular phenotype by continuous telemetric assessment, echocardiography, and direct arterial catheterization. We also explore blood vessel response using ex vivo myographic assessments. After this, we go on to examine the effect of knockout of Ddah2 on outcome, hemodynamics, and NO regulation in sepsis. We compare animals deficient in DDAH2 globally and also in mice lacking DDAH2 only in mature monocytes using a model of severe polymicrobial sepsis induced by caecal ligation and puncture (CLP).
Methods
Materials and Methods can be found in the online-only Data Supplement.
Results

Confirmation of ddah2 Gene Disruption
Knockout DDAH2 mice were generated in the expected Mendelian ratios, had no gross phenotype, and did not seem phenotypically different from their wild-type or heterozygous littermates. A tandem polymerase chain reaction method was developed to distinguish between the wild-type and null ddah2 alleles and to facilitate genotyping.
The ddah2 gene is located in a gene dense region of the major histocompatibility complex III locus. Thus, TaqMan quantitative RT-PCR was used to measure the expression of the genes flanking it. The relative expression of Ly6g6c, Clic1, and Rp23 (Mm.390956) RNA from Ddah2-deficient kidneys was not different than wild-type littermate controls (data not shown).
Western blots of kidney, heart, and liver tissue homogenates showed complete absence of DDAH2 protein in Ddah2 knockout animals ( Figure 1B ). This was confirmed with formal DDAH2 quantification. A reduced level of DDAH1 protein was observed in renal tissue homogenate in Ddah2 knockout mice ( Figure 1C ). In addition, Western blots confirmed the absence of DDAH2 protein in homogenates of spleen and lung from global knockout animals (data not shown). DDAH2 protein was demonstrated in aortic tissue in wild-type animals and shown to be absent in knockout mice ( Figure 1D ).
Methylarginine and NO Concentrations
In the global Ddah2 knockout (Ddah2 −/− ) animals, there was a significant increase in ADMA level compared with the wild type (Ddah2 Figure 2C ). Renal clearance of both ADMA and SDMA by the kidneys (as measured by urinary methylarginine concentration and corrected for urinary creatinine) was significantly elevated in knockout animals when compared with the wild-type littermates ( Figure 2D ). When exposed to a nitrate-free diet, a significant reduction in nitrate/nitrite (NOx) level was observed in plasma in knockout animals compared with wild-type controls (mean [ Figure 2E ).
In Vivo Radiotelemetry of Blood Pressure and Activity
In vivo assessment of circadian changes in hemodynamics revealed a trend toward elevation in average systolic (mean [SEM], 118.5 (6.4) versus 112.7 (3.1) mm Hg; P=0.40; Figure 3A ) and diastolic (mean [SEM], 93.7 (2.7) versus 87.76 (4.6) mm Hg; P=0.27; Figure 3B) hypothesis that DDAH2 deficiency attenuates NO signaling, administration of L-arginine 0.1% wt/vol to Ddah2 −/− animals for 3 days preceding telemetry resulted in a significant reduction in systolic blood pressure (P=0.04; Figure 3C ) not seen in arginine-treated Ddah2 +/+ animals ( Figure I in the online-only Data Supplement). − polymerase chain reaction product uses F (forward) and knockout (KO; reverse) primers, whereas Ddah2 + uses F and wild-type (WT; reverse) primers. B, Representative Western blots of dimethylarginine dimethylaminohydrolase 2 (DDAH2), DDAH1, and α-tubulin in kidney, liver, and heart extracts from Ddah2 +/+ versus Ddah2 −/− mice. Molecular mass of protein markers is indicated in kDa. C, Quantification of DDAH2 and DDAH1 protein distribution in heart, liver, and kidney tissue of Ddah2 global KO animals and WT littermates (n=4, *P<0.05). Levels were normalized to α-tubulin and presented as mean expression relative to Ddah2 +/+ controls. Error bars represent SE (n=4 animals); unpaired 2-tailed t test (*P<0.05; ***P<0.001). D, Representative image and quantification of DDAH2 distribution in aortas of Ddah2 global KO animals and WT littermates. Levels were quantified by densitometry, normalized to α-tubulin, and presented as mean expression relative to Ddah2 +/+ controls.
Ex Vivo Blood Vessel Reactivity
Myography was performed to determine if disruption of Ddah2 resulted in impaired NO-mediated vasoreactivity in global knockout animals under control conditions and at 24 hours after the onset of sepsis. In the control state, DDAH2-deficient vessels exhibited impaired relaxation in response to acetylcholine compared with the wild types (P<0.01, n=3; Figure 3D ). Figure 3Di ). The half-maximal dose of phenylephrine-induced contraction was significantly lower in Ddah2 −/− animals than in wild-type controls (P<0.01, n=3; Figure 3E ). The EC 50 of the response to the NO donor sodium nitroprusside was slightly and statistically significantly decreased in knockout mice ( Figure 3F ).
Anesthetized Models of Hemodynamics
In anesthetized models, no impact was seen in Ddah2 knockout on mean arterial pressure, heart rate, stroke volume, cardiac 
RNA Seq Analysis of the Impact of Inflammatory Stimulus on Resident Peritoneal Macrophages
RNA seq data showed that Ddah2 −/− animals displayed significant variation in the expression of a large number of genes after stimulus. There were >2000 genes with significantly different expression detected when treated wild-type cells were compared with macrophages from Ddah2 −/− animals (Table V in the online-only Data Supplement). Subsequent pathway analysis reveals strong association with several pathways related to immune and inflammatory responses (Table VI in the online-only Data Supplement). Data were of high quality for interpretation (Table VII in the online-only Data Supplement).
Impact of Global Ddah2 Knockout on Outcome in Sepsis
After CLP and induction of sepsis, a mortality study revealed a significant reduction in survival associated with global ). White bars: wild type, black bars: Ddah2 knockout animals; data presented as mean±SEM. Concentration of monomethyl-l-arginine (L-NMMA), asymmetric dimethylarginine (ADMA), and symmetric dimethylarginine (SDMA) in homogenates of heart tissue (A) and kidney tissue (B), measured by liquid chromatography-tandem mass spectrometry (n=8, unpaired t test, *P<0.05, otherwise no significant difference, P>0.05). Concentration of L-NMMA, ADMA, and SDMA in plasma (C) and urine (D) (n=18, unpaired t test, *P<0.05, otherwise no significant difference, P>0.05). E, Relative plasma concentration of nitrate+nitrite in nitrate-free diet fed animals (n=10, unpaired t test, *P<0.05).
knockout of Ddah2 at 120 hours after the induction of sepsis (52.9% versus 11.7%; P<0.001; Figure 4A ).
Bacterial Load Estimation in Plasma and Peritoneal Lavage
In a separate experiment, at 6 hours after the onset of sepsis, there was significant elevation in bacterial load in peritoneal lavage fluid in global knockout mice: 1.00×10 7 Figure 4B ).
Impact of Global DDAH2 Knockout on Methylarginine and NO Level in Sepsis
NOx was significantly elevated compared with animals that did not reach the illness severity threshold ( Figure 4C Figure 4E ) with no significant difference in plasma SDMA level detected ( Figure 4F ).
In Vivo Radiotelemetry of Blood Pressure and Activity in Sepsis
Continuous radiofrequency hemodynamic monitoring was undertaken following the onset of sepsis in Ddah2 −/− animals and their wild-type littermates. In a 72-hour period of telemetry, survival was 50% in Ddah2 +/+ animals and 17% in global knockouts with a median survival of 63 versus 33 hours, respectively. The last 24 hours of life was compared for each of the experimental animals and systolic ( Figure 5A ), diastolic ( Figure 5B), and mean ( Figure 5C ) Arterial blood pressures are compared. Although there were no significant hemodynamic differences between the groups at the point of experimental cessation, consistent with similar severity of illness, ) animals (P<0.05 wild type vs knockout) for median blood pressure >24 hours. C, Reversibility of hypertensive phenotype with l-arginine supplementation (P<0.05 knockout vs arginine-treated Ddah2 knockout and P=0.144 vs untreated wild-type control). Blood vessel relaxation or contraction measured in response to concentration curve of (D) acetylcholine (sub Figure 3Di: an a priori analysis of cardiovascular status at 12 hours before death revealed exaggerated hypotension in the Ddah2 −/− animals compared with controls in terms of systolic (P=0.03) and mean arterial pressure (P=0.03) with a trend toward a lower diastolic blood pressure (P=0.09) (Table IV in the online-only Data Supplement).
Confirmation of ddah2 Gene Disruption in Monocyte-Specific Ddah2 Knockout
Western blots of kidney, heart, liver, and aortic tissue homogenates showed preservation of DDAH2 protein in Ddah2 monocyte-specific knockout animals (Ddah2 
Ex Vivo Blood Vessel Reactivity in Sepsis
In a separate study, animals exposed to the established CLP model of sepsis were culled at 24 hours after induction of infection and aortas isolated for blinded analysis of vascular reactivity. Animals globally deficient in DDAH2 displayed both profound vasodilatation and impaired responsiveness when compared with baseline values. There were no significant differences in the responses to acetylcholine ( Figure 5D ) or phenylephrine ( Figure 5E ; n=6). There was a modest increase in response to sodium nitroprusside administration in vessels from DDAH2 −/− mice ( Figure 5F ; P<0.01, n=6) but no significant differences between responses of Ddah2 EC50 for all experiments can be seen in Table III in the onlineonly Data Supplement).
Comparison of Global and MonocyteSpecific DDAH2 Knockout in Sepsis
Evaluation of the monocyte-specific Ddah2 knockout animal developed using the loxP Cre Recombinase technique ( Figure 6A ) was undertaken in comparison with global knockout animals and relevant controls. Ddah2 mRNA was not detectable in macrophages extracted from Ddah2 M Φ − animals ( Figure 6B ). Using blinded independent assessment of severity and subcutaneous temperature as a surrogate marker, both Ddah2 −/− and Ddah2 M Φ − models displayed a higher incidence of severe illness by 72 hours (Ddah2 Figure 6C ). Greater change were observed in subcutaneous temperature at 18 
Bacterial Load Estimation in Plasma and Peritoneal Lavage
Peritoneal bacterial load was significantly elevated in macrophage-specific knockout mice (median [ Figure 6D ). Plasma NOx levels in the nonsurviving animals were similar in all groups ( Figure 6E ). Similar systemic derangement of ADMA and SDMA consistent with severe sepsis was observed in the Ddah2 MΦ− animals and their Ddah2 flox/flox controls ( Figure 6F and 6G).
Anesthetized In Vivo Hemodynamic Assessment in Sepsis
This elevation was similar to that previously observed in global knockout animals. Anaesthetized in vivo assessment of blood pressure 6 hours after the onset of sepsis did not reveal any significant differences in blood pressure between the 2 groups of animals ( Figure IVvi in the online-only Data Supplement).
Ex Vivo Assessment of DDAH2 Knockout on Macrophage Function
The impact of Ddah2 knockout on various aspects of macrophage function was assessed under basal and also conditions of polyfactorial inflammatory stimulus with interferon-γ, lipopolysaccharide, and tumor necrosis factor-α. Phagocytic ability at 4 hours was impaired in cells from global knockout and Ddah2 M Φ − animals under stimulus conditions ( Figure 7A ) as was motility at 24 hours ( Figure 7B ). Intracellular ADMA concentrations within resident peritoneal macrophages were significantly higher in the Ddah2 −/− animals compared with Ddah2 +/+ after treatment (P=0.03), with a trend to elevation in Ddah2 M Φ − monocytes ( Figure 7C ). NO production was impaired in knockout cells after polyfactorial stimulus compared with controls, including wild-type littermates and Cre-positive cells. Significant impairment was observed in the NO synthesis in both Ddah2 −/− and Ddah2 M Φ − compared with both Ddah2 +/+ and Cre-positive wild-type cells ( Figure 7D ). 
Discussion
ADMA is a physiological inhibitor of NOS and as such regulates NO production. It has been shown that DDAH1 inhibition is effective in reducing systemic NO via ADMA-mediated effects on NOS which attenuates the hypotensive phenotype 10 and improves survival in sepsis. 18 It has been suggested that DDAH2 may also play a role in both the physiological regulation of the cardiovascular system and also in the pathophysiological response to sepsis. 13 This is the first study to demonstrate a physiological role for DDAH2 and shows that knockout of the enzyme results in an animal with mild hypertension seen during periods of activity that is associated with elevated methylarginine concentrations and reciprocal reductions in systemic NO levels. This study also shows for the first time that in polymicrobial sepsis, Ddah2 deletion has a profound impact on NO production, immune function, and outcome, and it is macrophage DDAH2 that is a key regulator of this effect.
We have demonstrated that Ddah2 deletion in isolated cells and tissues results in elevation of ADMA and L-NMMA levels and a reduction in NO synthesis and NO signaling. Analysis of whole tissue homogenates confirms the observations from cells and tissues cultured ex vivo. Variations in methylarginine concentrations between tissues are likely related to variation in expression patterns of protein arginine methyl transferase enzymes responsible for methylarginine synthesis or changes in metabolism mediated by reduced NO bioavailability. We observe that Ddah2 deletion results in significant elevations of ADMA and SDMA in the urine. We and others have previously demonstrated that genetic deletion of alanine-glyoxylate aminotransferase 2 or pharmacological inhibition of this enzyme results in elevated circulating and urinary levels of both ADMA and SDMA. 21, 22 Therefore, the increased concentrations of asymmetric methylarginines in the kidney that result from Ddah2 deletion may be sufficient to compete with SDMA at the active site of alanine-glyoxylate aminotransferase 2 resulting in elevated accumulation of SDMA in the urine.
It has been established that DDAH2 metabolizes ADMA and overexpression of DDAH2 has been shown to increase resistance to the prohypertensive effects of exogenous ADMA administration in vivo. 23 Here, we have used a knockout model to explore the functional role of DDAH2. We show that under continuous radiotelemetry, mice deficient in DDAH2 have a modest but significant increase in systolic and diastolic blood pressures over their wild-type littermates and that this increase is particularly marked when the animals are active. Ex vivo examination of vascular responsiveness demonstrates significantly impaired relaxation in response to acetylcholine and exaggerated contraction after α-adrenergic stimulation with phenylephrine. We also observe a statistically significant decrease in sensitivity of isolated blood vessels to exogenously applied NO donors, however, the physiological significance of this observation is unclear. Interestingly, the hemodynamic alterations that we observed in conscious animals were negated under conditions of general anesthesia where vascular tone is impaired by central and systemic effects of the agents used.
The major histocompatibility complex region of chromosome 6 contains multiple genes involved in the immune response. The DDAH2 gene is found in the major histocompatibility complex III region 16 and polymorphisms of the promoter region of the gene have been shown to affect circulating ADMA levels and illness severity in both adult and pediatric populations with severe sepsis, 13, 14 however, the small number of subjects examined in these studies necessitates cautious interpretation of these data. Given these associations, we went on to explore the functional role of Ddah2 in sepsis using highly specific genetic modifications.
To evaluate the impact of these functional and biochemical changes have in vivo, we established a model of severe polymicrobial sepsis using CLP. We showed that although wildtype animals suffered a mortality rate of 47% at 120 hours, the mice deficient in DDAH2 had 88% mortality over the same period. This was related to elevation in bacterial load and consistent with reduced bactericidal ability of the DDAH2-deficient macrophages. We used a blinded assessment of illness severity score and subcutaneous temperature as objective indices 24 to facilitate examination of perimortem differences in NOx and methylarginine levels. We observed that in global DDAH2 knockout mice there was similar elevation of NOx in nonsurviving animals compared with controls. This measure of systemic NOx is not able to distinguish tissue-specific variation in NO production and the sensitivity of this test may be reduced by dietary nitrate. We did observe significant sepsisinduced elevations in both endogenous inhibitors of NO synthesis, with an exaggerated response in the global knockout animal. The elevation of plasma SDMA seen in the septic animals was similar in both knockout animals and their controls.
Continuous hemodynamic monitoring of global DDAH2 knockout animals revealed persistent hypotension in the last 12 hours of life compared with control animals. This is consistent with overwhelming infection in these animals because of impaired ability to mount an appropriate immune response and is not mediated by an increase in systemic NOx level. Ex vivo examination of vascular response suggests that the excess hypotension seen in Ddah2 knockout animals is not mediated by change in vascular responsiveness in DDAH2-deficient tissues, making an alternative mechanism of hypotension, such as systemic changes, mediated by increased bacterial load that likely cause.
Having postulated an impaired innate immune response because of excessive early death and impaired in vivo bactericidal function, we went on to show that NO production in activated macrophages is DDAH2-dependent with reduced NO levels and significant elevation in ADMA concentration within the cell. This in turn has a significant functional impact in terms of motility and phagocytosis ex vivo. This pattern of reduced function was similar to that which has been observed in monocytes deficient in the inducible isoform of NOS 25, 26 and is consistent with increased ADMA levels exerting an inhibitory effect on inducible NOS. These findings have been confirmed by RNA Seq analysis which suggests a significant impact of Ddah2 deletion on a series of immune and inflammatory pathways which are consistent with our functional and biochemical analyses. This hypothesis was confirmed using a loxP/Cre recombinase model to eliminate DDAH2 from mature monocytes. This model showed that in the absence of systemic changes in methylarginine level, survival of animals deficient in DDAH2 had a similar pattern of excess early mortality compared with their Ddah2 flox/flox littermates, this was associated with a similar pattern of elevated bacterial load in the peritoneum and blood to that observed in global knockout animals.
Knockout of our target enzyme in macrophages was undertaken using LoxP/Cre recombinase model and in the global knockout using terminal repeat sequence insertion. These models had a similar impact in terms of the biochemical and systemic response although as might be expected, a less profound increase in plasma ADMA and L-NMMA was seen in macrophage-specific knockouts when compared with the globally deficient animals. Using 2 different methods of genetic modification and comparing each group with relevant controls, we were able to eliminate any role played by off target effects of the technique and also ensure that the functional impact of DDAH2 was seen only in mature monocytes rather than progenitor or other cell types.
In summary, this study shows for the first time that DDAH2 regulates vascular tone under resting conditions with knockout of the ddah2 gene resulting in a modestly hypertensive phenotype. We have also demonstrated that animals deficient in DDAH2 either globally or within macrophages display significant impairment of NO-mediated immune function. We conclude that DDAH2 contributes to the response to severe bacterial sepsis in large part through its actions in regulating the macrophage inflammatory response. This data suggest that DDAH2 inhibition may be a therapeutic strategy in chronic inflammatory states where noninfective elevation of NO production is a component of the pathogenesis.
We postulate that this is a potential mechanism whereby the functional polymorphisms in the DDAH2 genes that we have previously identified and characterized might contribute to the prevalence of cardiovascular disease, 20, 27 as well as morbidity and mortality in sepsis. 13, 14 This may also provide a link between poor outcome in sepsis and patients with established cardiovascular disease with associated derangement of the ADMA regulatory pathway. 28, 29 Exploration of these hypotheses through large-scale clinical studies is warranted.
Nitric oxide plays a role in a diverse range of physiological and pathophysiological processes. The regulation of nitric oxide production in health and disease achieved by modulation of the concentration of endogenously produced inhibitors is of considerable interest in terms of both their mechanistic roles and as potential targets for therapeutic intervention. This study demonstrates for the first time that DDAH2 plays a role in both the regulation of hemodynamics under normal physiological conditions and also in determining the response to polymicrobial sepsis. This study provides novel insights into the way nitric oxide production, vascular function, and the immune response are regulated by DDAH2. Understanding this mechanism may lead to novel therapeutic approaches to the regulation of inflammation in chronic inflammatory disease states.
Significance
